
Zura Bio Announces Participation in Forthcoming Investor Conferences
Zura Bio Limited to Participate in Key March 2026 Investor Conferences in Miami Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotechnology company focused on developing innovative and differentiated therapies for patients living with serious autoimmune and inflammatory diseases, has announced…












